Josh Gottheimer bought Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 3 trades in Arcutis Biotherapeutics Inc (ARQT) since 2022, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of Arcutis Biotherapeutics Inc (NASDAQ: ARQT) on June 15, 2022. Since that trade, ARQT is up +36.20% against the S&P 500 up +106.70%, an outperformance of -70.50%.
Across these filings, Josh Gottheimer has been a net buyer of ARQT (a buy-to-sell ratio of 2.00). The most recent disclosed ARQT transaction shown was dated September 15, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's ARQT trades vs the price
ARQT is up +36.20% since Josh Gottheimer bought on June 15, 2022, versus +106.70% for the S&P 500.
Performance since this trade
All Josh Gottheimer ARQT trades
Josh Gottheimer & ARQT trading FAQ
Is it legal for Josh Gottheimer to trade Arcutis Biotherapeutics Inc (ARQT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Arcutis Biotherapeutics Inc (ARQT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer buy ARQT?
Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of Arcutis Biotherapeutics Inc (ARQT) on June 15, 2022, according to public STOCK Act filings.
How has ARQT performed since Josh Gottheimer's trade?
Since Josh Gottheimer bought ARQT on June 15, 2022, the stock is up +36.20%, versus +106.70% for the S&P 500 over the same period, an outperformance of -70.50%.
How many times has Josh Gottheimer traded ARQT?
Josh Gottheimer has disclosed 3 ARQT trades since 2022 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ARQT trades?
Quantellect tracks every disclosed congressional trade in Arcutis Biotherapeutics Inc (ARQT) on the Arcutis Biotherapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's ARQT tradesAll congressional filings for Arcutis Biotherapeutics IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.